Product Information
PREDNISONE 5 MG/5 ML SOLUTION is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.4331 per ML under NDC 00054372250. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 8, 1984.
Strength
5 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054372250
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREDNISONEApproval Type
Generic (ANDA)
FDA Application
ANDA088703FDA Approved
11/8/1984
On Market Since
11/8/1984
Pharmacological Classes
Price Statistics
The NADAC for PREDNISONE 5 MG/5 ML SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 176.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4331 per ML |
|---|---|
| All-time high | $0.6284 (Apr 10, 2019) |
| All-time low | $0.1567 (Nov 28, 2013) |
| 52-week high | $0.4858 |
| 52-week low | $0.4150 |
| Median price | $0.4594 |
| Average price | $0.4204 |
| Largest weekly change | +147.4% (Jan 17, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PredniSONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREDNISONE 5 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for PREDNISONE 5 MG/5 ML SOLUTION, manufactured by Hikma Pharmaceuticals USA Inc., is $0.4331 per ML (NDC 00054372250), effective Sep 30, 2026.
How has the price of PREDNISONE 5 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for PREDNISONE 5 MG/5 ML SOLUTION has risen 176.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREDNISONE 5 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for PREDNISONE 5 MG/5 ML SOLUTION has ranged from a low of $0.1567 (Nov 28, 2013) to a high of $0.6284 (Apr 10, 2019), with a median of $0.4594 per ML.
Are there cheaper alternatives to PREDNISONE 5 MG/5 ML SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PREDNISONE 5 MG/5 ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures PREDNISONE 5 MG/5 ML SOLUTION?
PREDNISONE 5 MG/5 ML SOLUTION (NDC 00054372250) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.